We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.225 | 5.81% | 4.10 | 4.05 | 4.15 | 4.275 | 3.825 | 3.88 | 29,115,559 | 16:25:52 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -4.32 | 21.05M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/7/2024 14:47 | Crashing in the close, baby rapist Z1co will be put down. | genghis_khan_ | |
25/7/2024 14:47 | News leaked sell on the news | genghis_khan_ | |
25/7/2024 14:46 | Beeksy Idiot read the post first before replying. I said on approval the share price will at least DOUBLE and that has got nothing to do with revenue. | z1co | |
25/7/2024 14:45 | I'd stick to FTSE 100 stocks Beeks if you're looking for a direct correlation between share price and earnings. So old school | socionomics | |
25/7/2024 14:42 | Thank Z1co.What revenues numbers are you basing that on? | premium beeks | |
25/7/2024 14:41 | What ever price the shares closes on Tuesday , they will at least DOUBLE on Wednesday once NICE confirms approval of CYP2C19 Test. | z1co | |
25/7/2024 14:41 | CPX on fire again. | socionomics | |
25/7/2024 14:32 | The £2B that's many years from today , short term i'm looking at £50m to £100m | z1co | |
25/7/2024 14:30 | News leaked sell on the news | genghis_khan_ | |
25/7/2024 14:29 | Batiatus25 Jul '24 - 14:19 - 6497 of 6497 0 0 0 A post by slacker over on LSE: What is the NEWS going to do for the share price??? You might get a small spike at best???? Are they goingvto break even before the 6 million runs out? Ate people really expecting overnight NHS rollout of the stoke marker test with BICE approval It's not been used front line!!! They will need data to support full rollout!!! 18 months to 2 years!!! Again will they break even before 6 million runs out?? Cmon rampers nswer the question that matters!!! Go to previous 6497 Jump to the specified article | genghis_khan_ | |
25/7/2024 14:26 | Why are you posting things from yesterday?Anyway, what's your thoughts on a 2b market cap here? Would you say none at all or can't you get the words out through chuckling? | premium beeks | |
25/7/2024 14:25 | News leaked sell on the news | genghis_khan_ | |
25/7/2024 14:19 | A post by slacker over on LSE: What is the NEWS going to do for the share price??? You might get a small spike at best???? Are they goingvto break even before the 6 million runs out? Ate people really expecting overnight NHS rollout of the stoke marker test with BICE approval It's not been used front line!!! They will need data to support full rollout!!! 18 months to 2 years!!! Again will they break even before 6 million runs out?? Cmon rampers nswer the question that matters!!! | batiatus | |
25/7/2024 14:13 | He's a baby rapist filth | genghis_khan_ | |
25/7/2024 14:13 | Crashing in the close, baby rapist Z1co will be put down. | genghis_khan_ | |
25/7/2024 14:10 | Lunch skipped today thanks, it's a discipline thing.I do think we see the bottom end of 3p by eow. Some might not be happy to hear it but it's the most likely scenario. | premium beeks | |
25/7/2024 13:44 | Friday sell off incoming Just like last Friday | batiatus | |
25/7/2024 13:38 | Over 7m buys compared to 4.8m sells and the price is slightly down.Yeterday was also the same. MM's games ? | z1co | |
25/7/2024 13:36 | Philpotts for lunch Beeksy? | socionomics | |
25/7/2024 13:34 | 425, 435, etc. | premium beeks | |
25/7/2024 13:25 | Beeks Don't be a LIAR , have not posted any such posts. You need to stop lying!!! | z1co | |
25/7/2024 13:11 | LOLOL She's just a little girly , maybe i'll go easy on her. | z1co |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions